ID   SIR6_HUMAN              Reviewed;         355 AA.
AC   Q8N6T7; B2RCD0; O75291; Q6IAF5; Q6PK99; Q8NCD2; Q9BSI5; Q9BWP3;
AC   Q9NRC7; Q9UQD1;
DT   31-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2003, sequence version 2.
DT   10-MAY-2017, entry version 147.
DE   RecName: Full=NAD-dependent protein deacetylase sirtuin-6;
DE            EC=3.5.1.-;
DE   AltName: Full=Regulatory protein SIR2 homolog 6;
DE   AltName: Full=SIR2-like protein 6;
GN   Name=SIRT6; Synonyms=SIR2L6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=10873683; DOI=10.1006/bbrc.2000.3000;
RA   Frye R.A.;
RT   "Phylogenetic classification of prokaryotic and eukaryotic Sir-2 like
RT   proteins.";
RL   Biochem. Biophys. Res. Commun. 273:793-798(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASN-46.
RC   TISSUE=Heart, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ASN-46.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ASN-46.
RC   TISSUE=Blood, Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16079181; DOI=10.1091/mbc.E05-01-0033;
RA   Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., Horikawa I.;
RT   "Evolutionarily conserved and nonconserved cellular localizations and
RT   functions of human SIRT proteins.";
RL   Mol. Biol. Cell 16:4623-4635(2005).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF HIS-133, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=18337721; DOI=10.1038/nature06736;
RA   Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H.,
RA   Damian M., Cheung P., Kusumoto R., Kawahara T.L.A., Barrett J.C.,
RA   Chang H.Y., Bohr V.A., Ried T., Gozani O., Chua K.F.;
RT   "SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric
RT   chromatin.";
RL   Nature 452:492-496(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-303, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   FUNCTION, INTERACTION WITH RELA, AND SUBCELLULAR LOCATION.
RX   PubMed=19135889; DOI=10.1016/j.cell.2008.10.052;
RA   Kawahara T.L.A., Michishita E., Adler A.S., Damian M., Berber E.,
RA   Lin M., McCord R.A., Ongaigui K.C.L., Boxer L.D., Chang H.Y.,
RA   Chua K.F.;
RT   "SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent
RT   gene expression and organismal life span.";
RL   Cell 136:62-74(2009).
RN   [12]
RP   FUNCTION.
RX   PubMed=19625767; DOI=10.4161/cc.8.16.9367;
RA   Michishita E., McCord R.A., Boxer L.D., Barber M.F., Hong T.,
RA   Gozani O., Chua K.F.;
RT   "Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56
RT   by human SIRT6.";
RL   Cell Cycle 8:2664-2666(2009).
RN   [13]
RP   FUNCTION, INTERACTION WITH RBBP8, AND MUTAGENESIS OF HIS-133.
RX   PubMed=20829486; DOI=10.1126/science.1192049;
RA   Kaidi A., Weinert B.T., Choudhary C., Jackson S.P.;
RT   "Human SIRT6 promotes DNA end resection through CtIP deacetylation.";
RL   Science 329:1348-1353(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-303 AND SER-330,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-294, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-318 IN COMPLEX WITH ZINC
RP   AND ADP-RIBOSE, AND FUNCTION.
RX   PubMed=21362626; DOI=10.1074/jbc.M111.218990;
RA   Pan P.W., Feldman J.L., Devries M.K., Dong A., Edwards A.M.,
RA   Denu J.M.;
RT   "Structure and biochemical functions of SIRT6.";
RL   J. Biol. Chem. 286:14575-14587(2011).
CC   -!- FUNCTION: NAD-dependent protein deacetylase. Has deacetylase
CC       activity towards histone H3K9Ac and H3K56Ac. Modulates acetylation
CC       of histone H3 in telomeric chromatin during the S-phase of the
CC       cell cycle. Deacetylates histone H3K9Ac at NF-kappa-B target
CC       promoters and may down-regulate the expression of a subset of NF-
CC       kappa-B target genes. Acts as a corepressor of the transcription
CC       factor HIF1A to control the expression of multiple glycolytic
CC       genes to regulate glucose homeostasis. Required for genomic
CC       stability. Regulates the production of TNF protein. Has a role in
CC       the regulation of life span (By similarity). Deacetylation of
CC       nucleosomes interferes with RELA binding to target DNA. May be
CC       required for the association of WRN with telomeres during S-phase
CC       and for normal telomere maintenance. Required for genomic
CC       stability. Required for normal IGF1 serum levels and normal
CC       glucose homeostasis. Modulates cellular senescence and apoptosis.
CC       On DNA damage, promotes DNA end resection via deacetylation of
CC       RBBP8. Has very weak deacetylase activity and can bind NAD(+) in
CC       the absence of acetylated substrate. {ECO:0000250,
CC       ECO:0000269|PubMed:18337721, ECO:0000269|PubMed:19135889,
CC       ECO:0000269|PubMed:19625767, ECO:0000269|PubMed:20829486,
CC       ECO:0000269|PubMed:21362626}.
CC   -!- CATALYTIC ACTIVITY: NAD(+) + an acetylprotein = nicotinamide + O-
CC       acetyl-ADP-ribose + a protein. {ECO:0000255|PROSITE-
CC       ProRule:PRU00236, ECO:0000269|PubMed:18337721}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Interacts with RELA. Interacts with RBBP8; the
CC       interaction deacetylates RBBP8. {ECO:0000269|PubMed:19135889,
CC       ECO:0000269|PubMed:20829486, ECO:0000269|PubMed:21362626}.
CC   -!- INTERACTION:
CC       P01106:MYC; NbExp=3; IntAct=EBI-712415, EBI-447544;
CC       Q04206:RELA; NbExp=4; IntAct=EBI-712415, EBI-73886;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:16079181, ECO:0000269|PubMed:18337721,
CC       ECO:0000269|PubMed:19135889}. Note=Predominantly nuclear.
CC       Associated with telomeric heterochromatin regions.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N6T7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N6T7-2; Sequence=VSP_008733;
CC         Note=No experimental confirmation available.;
CC   -!- MISCELLANEOUS: The reported ADP-ribosyltransferase activity of
CC       sirtuins is likely some inefficient side reaction of the
CC       deacetylase activity and may not be physiologically relevant.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the sirtuin family. Class IV subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC34468.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAD15478.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAH04218.1; Type=Erroneous translation; Note=Wrong choice of CCDS.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF233396; AAF43432.1; -; mRNA.
DR   EMBL; AK074810; BAC11222.1; -; mRNA.
DR   EMBL; AK315048; BAG37527.1; -; mRNA.
DR   EMBL; CR457200; CAG33481.1; -; mRNA.
DR   EMBL; AC005620; AAC34468.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC006930; AAD15478.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471139; EAW69252.1; -; Genomic_DNA.
DR   EMBL; BC004218; AAH04218.1; ALT_SEQ; mRNA.
DR   EMBL; BC005026; AAH05026.1; -; mRNA.
DR   EMBL; BC028220; AAH28220.1; -; mRNA.
DR   CCDS; CCDS12122.1; -. [Q8N6T7-1]
DR   CCDS; CCDS54199.1; -. [Q8N6T7-2]
DR   RefSeq; NP_001180214.1; NM_001193285.2. [Q8N6T7-2]
DR   RefSeq; NP_001307987.1; NM_001321058.1.
DR   RefSeq; NP_001307988.1; NM_001321059.1.
DR   RefSeq; NP_001307989.1; NM_001321060.1.
DR   RefSeq; NP_001307990.1; NM_001321061.1.
DR   RefSeq; NP_001307991.1; NM_001321062.1.
DR   RefSeq; NP_001307992.1; NM_001321063.1.
DR   RefSeq; NP_001307993.1; NM_001321064.1.
DR   RefSeq; NP_057623.2; NM_016539.3. [Q8N6T7-1]
DR   UniGene; Hs.423756; -.
DR   PDB; 3K35; X-ray; 2.00 A; A/B/C/D/E/F=3-318.
DR   PDB; 3PKI; X-ray; 2.04 A; A/B/C/D/E/F=2-355.
DR   PDB; 3PKJ; X-ray; 2.12 A; A/B/C/D/E/F=2-355.
DR   PDB; 3ZG6; X-ray; 2.20 A; A=1-296.
DR   PDB; 5MF6; X-ray; 1.87 A; A/B=13-308.
DR   PDB; 5MFP; X-ray; 1.98 A; A/B=13-308.
DR   PDB; 5MFZ; X-ray; 2.10 A; A/B=13-308.
DR   PDB; 5MGN; X-ray; 2.07 A; A/B=13-308.
DR   PDBsum; 3K35; -.
DR   PDBsum; 3PKI; -.
DR   PDBsum; 3PKJ; -.
DR   PDBsum; 3ZG6; -.
DR   PDBsum; 5MF6; -.
DR   PDBsum; 5MFP; -.
DR   PDBsum; 5MFZ; -.
DR   PDBsum; 5MGN; -.
DR   ProteinModelPortal; Q8N6T7; -.
DR   SMR; Q8N6T7; -.
DR   BioGrid; 119603; 176.
DR   DIP; DIP-47346N; -.
DR   IntAct; Q8N6T7; 17.
DR   MINT; MINT-1374731; -.
DR   STRING; 9606.ENSP00000337332; -.
DR   BindingDB; Q8N6T7; -.
DR   ChEMBL; CHEMBL2163182; -.
DR   GuidetoPHARMACOLOGY; 2712; -.
DR   iPTMnet; Q8N6T7; -.
DR   PhosphoSitePlus; Q8N6T7; -.
DR   BioMuta; SIRT6; -.
DR   DMDM; 38258612; -.
DR   EPD; Q8N6T7; -.
DR   MaxQB; Q8N6T7; -.
DR   PaxDb; Q8N6T7; -.
DR   PeptideAtlas; Q8N6T7; -.
DR   PRIDE; Q8N6T7; -.
DR   DNASU; 51548; -.
DR   Ensembl; ENST00000305232; ENSP00000305310; ENSG00000077463. [Q8N6T7-2]
DR   Ensembl; ENST00000337491; ENSP00000337332; ENSG00000077463. [Q8N6T7-1]
DR   GeneID; 51548; -.
DR   KEGG; hsa:51548; -.
DR   UCSC; uc002lzo.4; human. [Q8N6T7-1]
DR   CTD; 51548; -.
DR   DisGeNET; 51548; -.
DR   GeneCards; SIRT6; -.
DR   H-InvDB; HIX0014654; -.
DR   HGNC; HGNC:14934; SIRT6.
DR   HPA; HPA049729; -.
DR   HPA; HPA071776; -.
DR   MIM; 606211; gene.
DR   neXtProt; NX_Q8N6T7; -.
DR   OpenTargets; ENSG00000077463; -.
DR   PharmGKB; PA37939; -.
DR   eggNOG; KOG1905; Eukaryota.
DR   eggNOG; COG0846; LUCA.
DR   GeneTree; ENSGT00530000063706; -.
DR   HOVERGEN; HBG060028; -.
DR   InParanoid; Q8N6T7; -.
DR   KO; K11416; -.
DR   OMA; NVLDWEH; -.
DR   OrthoDB; EOG091G0FOW; -.
DR   PhylomeDB; Q8N6T7; -.
DR   TreeFam; TF106184; -.
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   SIGNOR; Q8N6T7; -.
DR   ChiTaRS; SIRT6; human.
DR   EvolutionaryTrace; Q8N6T7; -.
DR   GeneWiki; SIRT6; -.
DR   GenomeRNAi; 51548; -.
DR   PRO; PR:Q8N6T7; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000077463; -.
DR   ExpressionAtlas; Q8N6T7; baseline and differential.
DR   Genevisible; Q8N6T7; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005724; C:nuclear telomeric heterochromatin; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003956; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0003950; F:NAD+ ADP-ribosyltransferase activity; TAS:BHF-UCL.
DR   GO; GO:0070403; F:NAD+ binding; ISS:UniProtKB.
DR   GO; GO:0017136; F:NAD-dependent histone deacetylase activity; ISS:UniProtKB.
DR   GO; GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IDA:UniProtKB.
DR   GO; GO:0034979; F:NAD-dependent protein deacetylase activity; TAS:Reactome.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Ensembl.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0006284; P:base-excision repair; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0046325; P:negative regulation of glucose import; IEA:Ensembl.
DR   GO; GO:0045820; P:negative regulation of glycolytic process; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:1905555; P:positive regulation blood vessel branching; IMP:BHF-UCL.
DR   GO; GO:1902732; P:positive regulation of chondrocyte proliferation; IMP:BHF-UCL.
DR   GO; GO:0031940; P:positive regulation of chromatin silencing at telomere; IMP:BHF-UCL.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; IEA:Ensembl.
DR   GO; GO:0032206; P:positive regulation of telomere maintenance; IMP:BHF-UCL.
DR   GO; GO:1905549; P:positive regulation of telomeric heterochromatin assembly; IMP:BHF-UCL.
DR   GO; GO:1905564; P:positive regulation of vascular endothelial cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0003247; P:post-embryonic cardiac muscle cell growth involved in heart morphogenesis; IEA:Ensembl.
DR   GO; GO:0006471; P:protein ADP-ribosylation; ISS:UniProtKB.
DR   GO; GO:0031648; P:protein destabilization; IEA:Ensembl.
DR   GO; GO:0010569; P:regulation of double-strand break repair via homologous recombination; IDA:UniProtKB.
DR   GO; GO:0031667; P:response to nutrient levels; IEA:Ensembl.
DR   Gene3D; 3.40.50.1220; -; 1.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR003000; Sirtuin.
DR   InterPro; IPR026590; Ssirtuin_cat_dom.
DR   Pfam; PF02146; SIR2; 2.
DR   SUPFAM; SSF52467; SSF52467; 1.
DR   PROSITE; PS50305; SIRTUIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Hydrolase; Metal-binding; NAD; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    355       NAD-dependent protein deacetylase
FT                                sirtuin-6.
FT                                /FTId=PRO_0000110269.
FT   DOMAIN       35    274       Deacetylase sirtuin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00236}.
FT   NP_BIND      52     71       NAD.
FT   NP_BIND     113    116       NAD.
FT   NP_BIND     214    216       NAD.
FT   NP_BIND     240    242       NAD.
FT   COMPBIAS    287    345       Pro-rich.
FT   ACT_SITE    133    133       Proton acceptor.
FT   METAL       141    141       Zinc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00236,
FT                                ECO:0000269|PubMed:21362626}.
FT   METAL       144    144       Zinc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00236,
FT                                ECO:0000269|PubMed:21362626}.
FT   METAL       166    166       Zinc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00236,
FT                                ECO:0000269|PubMed:21362626}.
FT   METAL       177    177       Zinc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00236,
FT                                ECO:0000269|PubMed:21362626}.
FT   BINDING     258    258       NAD; via amide nitrogen.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     294    294       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     303    303       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     330    330       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     179    205       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008733.
FT   VARIANT      46     46       S -> N (in dbSNP:rs352493).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_017154.
FT   MUTAGEN     133    133       H->Y: Loss of enzyme activity. Abolishes
FT                                RBBP8 deacetylation and promotion of DNA
FT                                end resection after DNA damage.
FT                                {ECO:0000269|PubMed:18337721,
FT                                ECO:0000269|PubMed:20829486}.
FT   CONFLICT     42     42       W -> R (in Ref. 3; CAG33481).
FT                                {ECO:0000305}.
FT   CONFLICT    249    249       H -> Y (in Ref. 6; AAH04218).
FT                                {ECO:0000305}.
FT   CONFLICT    267    267       K -> E (in Ref. 1; AAF43432).
FT                                {ECO:0000305}.
FT   TURN          5      8       {ECO:0000244|PDB:3ZG6}.
FT   HELIX        27     43       {ECO:0000244|PDB:5MF6}.
FT   STRAND       47     51       {ECO:0000244|PDB:5MF6}.
FT   HELIX        53     59       {ECO:0000244|PDB:5MF6}.
FT   STRAND       64     66       {ECO:0000244|PDB:5MF6}.
FT   HELIX        70     75       {ECO:0000244|PDB:5MF6}.
FT   TURN         86     88       {ECO:0000244|PDB:5MF6}.
FT   HELIX        93    103       {ECO:0000244|PDB:5MF6}.
FT   STRAND      108    112       {ECO:0000244|PDB:5MF6}.
FT   HELIX       118    121       {ECO:0000244|PDB:5MF6}.
FT   STRAND      122    125       {ECO:0000244|PDB:3PKI}.
FT   HELIX       126    128       {ECO:0000244|PDB:5MF6}.
FT   STRAND      129    131       {ECO:0000244|PDB:5MF6}.
FT   STRAND      138    141       {ECO:0000244|PDB:5MF6}.
FT   TURN        142    144       {ECO:0000244|PDB:5MF6}.
FT   STRAND      147    149       {ECO:0000244|PDB:5MF6}.
FT   STRAND      161    165       {ECO:0000244|PDB:5MF6}.
FT   TURN        171    174       {ECO:0000244|PDB:3ZG6}.
FT   STRAND      180    183       {ECO:0000244|PDB:5MF6}.
FT   STRAND      188    190       {ECO:0000244|PDB:3PKJ}.
FT   HELIX       194    206       {ECO:0000244|PDB:5MF6}.
FT   STRAND      208    214       {ECO:0000244|PDB:5MF6}.
FT   HELIX       222    224       {ECO:0000244|PDB:5MF6}.
FT   HELIX       225    229       {ECO:0000244|PDB:5MF6}.
FT   HELIX       230    232       {ECO:0000244|PDB:5MF6}.
FT   STRAND      235    239       {ECO:0000244|PDB:5MF6}.
FT   HELIX       247    249       {ECO:0000244|PDB:5MF6}.
FT   STRAND      251    254       {ECO:0000244|PDB:5MF6}.
FT   HELIX       258    268       {ECO:0000244|PDB:5MF6}.
FT   STRAND      278    280       {ECO:0000244|PDB:5MF6}.
SQ   SEQUENCE   355 AA;  39119 MW;  0C86AAC497130BBF CRC64;
     MSVNYAAGLS PYADKGKCGL PEIFDPPEEL ERKVWELARL VWQSSSVVFH TGAGISTASG
     IPDFRGPHGV WTMEERGLAP KFDTTFESAR PTQTHMALVQ LERVGLLRFL VSQNVDGLHV
     RSGFPRDKLA ELHGNMFVEE CAKCKTQYVR DTVVGTMGLK ATGRLCTVAK ARGLRACRGE
     LRDTILDWED SLPDRDLALA DEASRNADLS ITLGTSLQIR PSGNLPLATK RRGGRLVIVN
     LQPTKHDRHA DLRIHGYVDE VMTRLMKHLG LEIPAWDGPR VLERALPPLP RPPTPKLEPK
     EESPTRINGS IPAGPKQEPC AQHNGSEPAS PKRERPTSPA PHRPPKRVKA KAVPS
//
